Metabolic evaluation should include fasting glucose, insulin levels, and HOMA-IR to establish baseline insulin sensitivity
Beyond glycemic control, GLP-1 receptor agonists slow gastric emptying, prolonging the sensation of fullness after meals
The product is not registered in Nigeria and did not pass through authorized Johnson & Johnson distributors
Quick Answer: The right GLP-1 medication for you depends on your cardiovascular status, weight management goals, dosing preference (daily versus weekly), renal function, and insurance coverage
Therefore, to safely harness the attractive catabolic and thermogenic effects of glucagon for treating metabolic disease, a counter-balancing therapy that selectively opposes the risk for glucagon-induced hyperglycaemia is required
Enter: electrolyte drinks